View Cart  

FDA Warning Letter Cites Canadian Drugmaker for Vendor Qualification Lapses

A A
The FDA has hit International Laboratories Canada with a warning letter for good manufacturing practice (GMP) violations related to supplier qualification and the company’s quality control unit.

To View This Article:

Login

Subscribe To Drug Industry Daily